NCT05590598 - Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis. | Biotech Hunter

Enrollment

472

Participants

Timeline

Start Date

February 13, 2023

Primary Completion Date

June 14, 2023

Study Completion Date

June 14, 2023

Conditions

Seasonal Allergic Rhinitis

Interventions

COMBINATION_PRODUCT

Azelastine + Mometazone, nasal spray

140 mcg + 50 mcg/dose (Sandoz d.d., Slovenia), one actuation in each nostril twice daily, morning and evening (recommended interval between administrations is approximately 12 hours), for 14 consecutive days.

COMBINATION_PRODUCT

Momat Rhino Advance

140 µg + 50 µg/dose - one actuation into each nostril twice daily - morning and evening (interval between administrations is 12 hrs), corresponding to 560 µg/day of azelastine and 200 µg/day of mometasone for 14 consecutive days

Trial Locations (15)